Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-12

Clinical Trial Update: DPA-714 and FDG PET/MRI in Depression [NA]

View source ↗

Summary

A recruiting clinical trial at The First Affiliated Hospital of Dalian Medical University studies DPA-714 with FDG PET/MRI in depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DPA-714 (DPA-714 (a TSPO ligand))

Snippet

Sponsor: The First Affiliated Hospital of Dalian Medical University | Conditions: Depression | NA | Status: RECRUITING